PAR6 ECONOMIC EVALUATION OF THERAPY WITH NSAIDAND WITH COX-2 IN SUBJECTS AGED 66 YEARS OR MORE
Abstract
Authors
L Santoni L Da Deppo LG Mantovani
L Santoni L Da Deppo LG Mantovani
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now